MedTrace Logo

Function of Implanted Glucose Sensor 2

NCT02345967 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-06-13

No results posted yet for this study

Summary

The purpose of this study is to verify safety and assess tolerance of a long-term, implanted glucose monitoring sensor. The study will also provide data to characterize the response properties and calibration of the implanted sensor and determine if such properties vary with implant duration.

Conditions

Interventions

DEVICE

Model 100 Sensor

One Model 100 Sensor to be implanted per subject.

Sponsors & Collaborators

  • Profil Institute for Clinical Research, Inc.

    collaborator OTHER

  • AMCR Institute

    collaborator OTHER

  • GlySens Incorporated

    lead INDUSTRY

Principal Investigators

  • Linda Morrow, MD · Profil Institute for Clinical Research, Inc.

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-05-30
Completion
2018-05-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02345967 on ClinicalTrials.gov